Skip to main content
MediciNova,Inc. logo

MediciNova,Inc. — Investor Relations & Filings

Ticker · 4875 ISIN · US58468P2065 T Manufacturing
Open in API
Filings indexed 59 across all filing types
Latest filing 2023-12-12 Regulatory Filings
Country JP Japan
Listing T 4875

About MediciNova,Inc.

https://medicinova.com/

MediciNova, Inc. is a clinical-stage biopharmaceutical company that acquires and develops novel, small-molecule therapeutics. The company's late-stage pipeline focuses on addressing unmet medical needs in neurology, respiratory, and liver diseases. Key development programs include MN-166 (ibudilast) for neurological conditions, MN-001 (tipelukast) for fibrotic diseases such as liver fibrosis (NASH) and pulmonary fibrosis (IPF), and MN-221 for respiratory conditions including acute exacerbations of asthma and COPD.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act of Japan. It serves as an officer certification by the CEO and CFO confirming the accuracy of the company's quarterly report. According to the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a specific report (like a quarterly report), should be classified as Regulatory Filings (RNS) rather than the report itself. Q3 2023
2023-12-12 Japanese
四半期報告書
Interim / Quarterly Report Classification · 100% confidence The document is a '四半期報告書' (Quarterly Report) filed by MediciNova, Inc. with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, management discussion and analysis, and corporate information for the fiscal period from July 1, 2023, to September 30, 2023. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. 9M 2023
2023-12-12 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act of Japan. It serves as an officer certification by the CEO and CFO confirming the accuracy of the company's quarterly report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report type (like a quarterly report), should be classified as Regulatory Filings (RNS) rather than the report itself. Q2 2023
2023-09-12 Japanese
四半期報告書
Interim / Quarterly Report Classification · 100% confidence The document is a '四半期報告書' (Quarterly Report) filed by MediciNova, Inc. with the Kanto Local Finance Bureau in Japan. It contains detailed financial data, including balance sheets, income statements, and cash flow statements for the quarterly period ending June 30, 2023. It also includes management's discussion and analysis of the company's business and financial condition. This fits the definition of an Interim/Quarterly Report (IR). H1 2023
2023-09-12 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (Kakuninsho) filed under the Financial Instruments and Exchange Act of Japan. It serves as an officer certification by the CEO and CFO confirming the accuracy of the company's quarterly report. Per the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report (like a quarterly report), should be classified as Regulatory Filings (RNS) rather than the report itself. Q1 2023
2023-06-13 Japanese
四半期報告書
Interim / Quarterly Report Classification · 100% confidence The document is a '四半期報告書' (Quarterly Report) filed with the Kanto Local Finance Bureau in Japan. It contains detailed financial data, including balance sheets, income statements, and cash flow statements for the quarterly period ending March 31, 2023. It also includes management discussion and analysis (MDA) and corporate information. This fits the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-06-13 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.